AzurRx BioPharma to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference
AzurRx BioPharma to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference
DELRAY BEACH, Fla., Jan. 06, 2021 AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that the Company will be participating in the virtual H.C. Wainwright BioConnect 2021 Conference.
James Sapirstein, President & CEO of AzurRx BioPharma, will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company’s business and clinical development programs and discuss anticipated 2021 milestones.
News Details - 3E Accounting first Asia-Pacific First Robotics Accounting Firm internationalaccountingbulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from internationalaccountingbulletin.com Daily Mail and Mail on Sunday newspapers.